Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bernstein launches coverage of Canada’s Tilray, Cronos and Canopy Growth but stops short of any buy ratings

By: MarketWatch
Analyst Nadine Sarwat sees Cronos and Tilray as 'fairly valued' and Canopy Growth as 'meaningfully overvalued.'
Related Stocks:
Acreage Holdings AdvisorShares Trust AdvisorShares Pure US Cannabis ETF Altria Group Canopy Growth Corporation - Common Shares Compass, Inc. Class A Common Stock Cronos Group Inc. - Common Share Spinnaker ETF Series The Cannabis ETF Tilray Brands, Inc. - Common Stock
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.